A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Weight loss is a long process that requires a lot of effort and time. Even though this might be true, some people might feel like the efforts they put in are never rewarded properly. This might not be ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The bill would prevent processed foods that contain any of 11 different additives from being sold in Arizona's public schools.

With President Donald Trump back in the White House, several American doctors are welcoming the new administration’s greater ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...